COVID-19 Saliva Screening Test Market Size, Share, Revenue, Trends And Drivers For 2024-2033
COVID-19 Saliva Screening Test Potential Global Market Report 2024 – Market Trends, And Global Forecast 2024-2033
The Business Research Company has updated its global market reports with latest data for 2024 and projections up to 2033
LONDON, GREATER LONDON , UK, July 22, 2024 /EINPresswire.com/ -- The COVID-19 saliva screening test market has experienced robust growth in recent years. It is anticipated to expand from $3.57 billion in 2023 to $3.90 billion in 2024, marking a compound annual growth rate (CAGR) of 9.3%. It will grow to $5.64 billion in 2028 at a compound annual growth rate (CAGR) of 9.6%. This growth has been driven by the potential for home testing, an unprecedented need for diagnostic testing, heightened public awareness, and significant investments in research and development.
Rising Healthcare Expenditure Fuels Market Expansion
The increasing healthcare expenditure is a crucial factor propelling the growth of the COVID-19 saliva screening test market. Higher healthcare spending enables the acquisition of advanced diagnostic tools and supports more effective pandemic management. In May 2023, the Office for National Statistics reported a 9.7% increase in the UK's healthcare expenditure, underlining the trend of rising investments in health services. This financial support enhances the deployment and effectiveness of saliva-based screening tests, contributing to better public health outcomes.
Explore comprehensive insights into the global COVID-19 saliva screening test market with a detailed sample report: https://www.thebusinessresearchcompany.com/sample_request?id=16026&type=smp
COVID-19 Saliva Screening Test Potential Market Key Players2 and Innovations
Leading companies in the COVID-19 saliva screening test market include Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, and Becton Dickinson and Company. These firms are advancing the field through innovative programs. For instance, Mount Sinai Health System launched the Mount Sinai COVID-19 PCR Saliva Testing program in April 2021, which offers quick, non-invasive testing with results available within 24 hours. This initiative highlights the industry's focus on expanding testing capabilities and improving accessibility.
Major Trends Shaping the Market
Key trends in the forecast period include:
• Increased adoption of saliva tests in non-healthcare settings
• Integration with digital health platforms
• Emergence of next-generation technologies
• Technological advancements in testing methods
• Strategic partnerships to enhance market reach
These trends reflect the industry's efforts to innovate and adapt to evolving needs and technological advancements.
COVID-19 Saliva Screening Test Potential Market Segmentation3
The COVID-19 saliva screening test market is segmented as follows:
• By Location: Travel Stations, Sports Arenas, Entertainment Venues, Corporate Campus Environments, Universities and Colleges, Factories, Other Locations
• By Technology: Fluorescence-Labelled Antigen, RT-PCR, CRISPR-Cas9
• By Mode of Testing: Centralized Testing, Decentralized Testing
Geographical Insights: North America Leading the Market
North America was the largest region in the COVID-19 saliva screening test market in 2023 and is expected to continue its leadership. The region's advanced healthcare infrastructure and high demand for efficient testing solutions support its dominant position in the market.
Explore the report store to make a direct purchase of the report
https://www.thebusinessresearchcompany.com/report/covid-19-saliva-screening-test-potential-global-market-report
COVID-19 Saliva Screening Test Potential Global Market Report 2024 from TBRC covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Trends, opportunities, strategies and so much more.
The COVID-19 Saliva Screening Test Potential Global Market Report 2024 by The Business Research Company1 is the most comprehensive report that provides insights on COVID-19 saliva screening test potential market size, COVID-19 saliva screening test potential market drivers and trends, COVID-19 saliva screening test potential market major players, competitors' revenues, market positioning, and market growth across geographies. The COVID-19 saliva screening test potential market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.
Browse Through More Similar Reports By The Business Research Company:
Drug Screening Global Market Report 202
https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report
Security Screening Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/security-screening-global-market-report
Crushing, Screening, And Mineral Processing Equipment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/crushing-screening-and-mineral-processing-equipment-global-market-report
About The Business Research Company
The Business Research Company has published over 15000+ reports covering 27 industries, spanning over 8000+ markets and 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.
Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn
1 https://www.thebusinessresearchcompany.com/
2 https://www.thebusinessresearchcompany.com/report/covid-19-saliva-screening-test-potential-global-market-report
3 https://www.thebusinessresearchcompany.com/report/covid-19-saliva-screening-test-potential-global-market-report
